mitotane has been researched along with cabazitaxel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abate, A; Ambrosini, R; Berruti, A; Canu, L; Cosentini, D; Ferrari, VD; Gianoncelli, A; Grisanti, S; Laganà , M; Sigala, S; Terzolo, M; Tiberio, GAM; Turla, A; Zamparini, M | 1 |
1 trial(s) available for mitotane and cabazitaxel
Article | Year |
---|---|
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Humans; Mitotane; Taxoids | 2022 |